Chemoinformaics analysis of 1-Methyl-1-propylhydrazine
Molecular Weight | 88.154 | nRot | 2 |
Heavy Atom Molecular Weight | 76.058 | nRig | 0 |
Exact Molecular Weight | 88.1001 | nRing | 0 |
Solubility: LogS | 0.923 | nHRing | 0 |
Solubility: LogP | 0.128 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 16.8815 |
nHD | 1 | BPOL | 12.0385 |
QED | 0.386 |
Synth | 2.875 |
Natural Product Likeliness | -1.128 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.04 |
HIA | 0.003 |
CACO-2 | -4.647 |
MDCK | 0.0000198 |
BBB | 0.488 |
PPB | 0.056406 |
VDSS | 1.324 |
FU | 0.886113 |
CYP1A2-inh | 0.122 |
CYP1A2-sub | 0.387 |
CYP2c19-inh | 0.027 |
CYP2c19-sub | 0.902 |
CYP2c9-inh | 0.004 |
CYP2c9-sub | 0.148 |
CYP2d6-inh | 0.009 |
CYP2d6-sub | 0.869 |
CYP3a4-inh | 0.002 |
CYP3a4-sub | 0.215 |
CL | 8.351 |
T12 | 0.617 |
hERG | 0.024 |
Ames | 0.124 |
ROA | 0.947 |
SkinSen | 0.758 |
Carcinogencity | 0.956 |
EI | 0.804 |
Respiratory | 0.971 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.959727 |